Archive · 26 Jul 2025
Dr. Reddy's Invests ₹565 Crore in Russian Subsidiary
Dr. Reddy's Laboratories, a company that makes medicine, invested a large sum of money, ₹565 crore, into its Russian branch, DRL Russia.
They now own a bigger part of the Russian branch, about half of it.
The company decided to do this in late 2024 and finished the deal on July 25, 2025.
The money will help the Russian branch buy supplies and pay for things it needs to keep running.
The Russian branch sells medicine in Russia.
Dr. Reddy's Laboratories invested ₹565 crore in its Russian subsidiary.
The investment was made in DRL Russia, acquiring a 45.19% equity stake.
The board decided to infuse up to ₹600 crore in November 2024.
The investment was completed on July 25, 2025.
The funds will be used for working capital requirements.
- Who
- Dr Reddy's Laboratories.
- What
- Dr. Reddy's Laboratories invested ₹565 crore in its Russian subsidiary, acquiring a 45.19% equity stake.
- When
- The investment was completed on July 25, 2025.
- Where
- In Dr Reddy's Laboratories LLC, Russia (DRL Russia).
- Why
- The funds will be used for working capital requirements.
- Investment Amount
- ₹565 crore
- Recipient
- Dr Reddy's Laboratories LLC, Russia
- Equity Stake Acquired
- 45.19%
- Board Decision
- November 2024
- Purpose of Funds
- Working capital
- DRL Russia Incorporation
- April 5, 2003
- DRL Russia Turnover (2024-25)
- ₹2,347 crore